| Sunshine Health Clinical Policy | Vagus Nerve Stimulation | 2025-07-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Cognitive Rehabilitation Therapy | 2025-07-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Dental Therapy Under General Anesthesia | 2025-07-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Diabetic Supplies | 2025-07-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Cognitive Rehabilitation Therapy | 2025-07-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Dental Therapy Under General Anesthesia | 2025-07-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Diabetic Supplies | 2025-07-01 |
| UHC Commercial Medical & Drug | Adzynma (ADAMTS13, Recombinant-Krhn) – Commercial Medical Benefit Drug Policy | 2025-07-01 |
| UHC Commercial Medical & Drug | Amondys 45® (Casimersen) – Commercial Medical Benefit Drug Policy | 2025-07-01 |
| UHC Commercial Medical & Drug | Entyvio® (Vedolizumab) – Commercial Medical Benefit Drug Policy | 2025-07-01 |